Angiotensin II-induced transcriptional activation of the cyclin D1 gene is mediated by Egr-1 in CHO-AT1A cells

被引:63
作者
Guillemot, L [1 ]
Levy, A [1 ]
Raymondjean, M [1 ]
Rothhut, B [1 ]
机构
[1] Univ Paris 06, UMR Physiol & Physiopathol, F-75005 Paris, France
关键词
D O I
10.1074/jbc.M103862200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cyclin D1 protein expression is regulated by mitogenic stimuli and is a critical component in the regulation of G(1) to S phase progression of the cell cycle. Angiotensin II (Ang II) binds to specific G protein-coupled receptors and is mitogenic in Chinese hamster ovary cells stably expressing the rat vascular Ang II type IA receptor (CHO-AT(1A)). We recently reported that in these cells, Ang II induced cyclin Dl promoter activation and protein expression in a phosphatidylinositol 3-kinase (PI3K)-, SHP-2-, and mitogen-activated protein kinase/ extracellular signal-regulated kinase (MAPK/ERK)-dependent manner (Guillemot, L., Levy, A., Zhao, Z. J., Bereziat, G., and Rothhut, B. (2000) J. Biol. Chem. 275, 26349-26358). In this report, transfection studies using a series of deleted cyclin D1 promoters revealed that two regions between base pairs (bp) -136 and -96 and between by -29 and +139 of the human cyclin Dl promoter contained regulatory elements required for Ang II-mediated induction. Mutational analysis in the -136 to -96 by region provided evidence that a Sp1/early growth response protein (Egr) motif was responsible for cyclin Dl promoter activation by Ang II. Gel shift and supershift studies showed that Ang II-induced Egr-1 binding involved de novo protein synthesis and correlated well with Egr-1 promoter activation. Both U0126 (an inhibitor of the MAPK/ERK kinase MEK) and wortmannin (an inhibitor of PI3K) abrogated Egr-1 endogenous expression and Egr-1 promoter activity induced by Ang II. Moreover, using a co-transfection approach, we found that Ang II induction of Egr-1 promoter activity was blocked by dominant-negative p21(ras), Raf-1, and tyrosine phosphatase SHP-2 mutants. Identical effects were obtained when inhibitors and dominant negative mutants were tested on the -29 to +139 by region of the cyclin DI promoter. Taken together, these findings demonstrate that Ang II-induced cyclin Dl up-regulation is mediated by the activation and specific interaction of Egr-1 with the -136 to -96 by region of the cyclin Dl promoter and by activation of the -29 to +139 by region, both in a p21(ras)/Raf-1/MEK/ERK-dependent manner, and also involves PI3K and SHP-2.
引用
收藏
页码:39394 / 39403
页数:10
相关论文
共 83 条
[21]   DIFFERENTIAL ACTIVATION OF THE RAT PHENYLETHANOLAMINE N-METHYLTRANSFERASE GENE BY SP1 AND EGR-1 [J].
EBERT, SN ;
WONG, DL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (29) :17299-17305
[22]   ERK PHOSPHORYLATION POTENTIATES ELK-1-MEDIATED TERNARY COMPLEX-FORMATION AND TRANSACTIVATION [J].
GILLE, H ;
KORTENJANN, M ;
THOMAE, O ;
MOOMAW, C ;
SLAUGHTER, C ;
COBB, MH ;
SHAW, PE .
EMBO JOURNAL, 1995, 14 (05) :951-962
[23]   The protein-tyrosine phosphatase SHP-2 is required during angiotensin II-mediated activation of cyclin D1 promoter in CHO-AT1A cells [J].
Guillemot, L ;
Levy, A ;
Zhao, ZJ ;
Béréziat, G ;
Rothhut, B .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (34) :26349-26358
[24]  
Guttridge DC, 1999, MOL CELL BIOL, V19, P5785
[25]   Reduced O glycosylation of Sp1 is associated with increased proteasome susceptibility [J].
Han, I ;
Kudlow, JE .
MOLECULAR AND CELLULAR BIOLOGY, 1997, 17 (05) :2550-2558
[26]  
HERBER B, 1994, ONCOGENE, V9, P1295
[27]   Growth hormone stimulates phosphorylation and activation of Elk-1 and expression of c-fos, egr-1, and junB through activation of extracellular signal-regulated kinases 1 and 2 [J].
Hodge, C ;
Liao, JF ;
Stofega, M ;
Guan, KL ;
Carter-Su, C ;
Schwartz, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (47) :31327-31336
[28]   CYCLINS AND CANCER .2. CYCLIN-D AND CDK INHIBITORS COME OF AGE [J].
HUNTER, T ;
PINES, J .
CELL, 1994, 79 (04) :573-582
[29]   TRANSCRIPTION FACTOR AP-2 MEDIATES INDUCTION BY 2 DIFFERENT SIGNAL-TRANSDUCTION PATHWAYS - PROTEIN-KINASE-C AND CAMP [J].
IMAGAWA, M ;
CHIU, R ;
KARIN, M .
CELL, 1987, 51 (02) :251-260
[30]  
INAGAMI T, 1994, J HYPERTENS, V12, pS83